A great deal of effort continues to be spent on hospital readmissions and their prevention. The most recent issue of JAMA has several studies and analyses on the issue. (JAMA Issue) The subject continues to be very timely, given that the CMS penalty program started this year. One analyses notes the continuing lack of clear evidence that readmission rate is a quality indicator. Another notes the concern for any pay for performance program of the possible gaming of the coding systems used to compile data for most of these programs. One study looked at patterns of readmissions, finding that the diagnoses were often different from the original hospitalization diagnoses, that readmissions occurred regularly throughout the typical 30-day period used to judge inappropriate admissions and that few, if any, patient characteristics seem associated with likely readmissions. Another study noted that many recent dischargees have emergency room visits as well, so care transitions should focus on those as well as readmissions. Pediatric readmissions were studied in one report, with a finding of variability across hospitals and across admission conditions. The association between a care transition quality improvement effort and rehospitalizations was found to be generally lacking, with no change in the rate as a percent of hospital discharges, although the absolute number of hospitalizations and readmissions did decline. The net effect left on the reader is the conclusion that most readmitted patients are just very sick and probably need to be in the hospital to get adequate care; demonstrating once again both the futility and punitive nature of the CMS program.
✅ Subscribe via Email
About this Blog
The Healthy Skeptic is a website about the health care system, and is written by Kevin Roche, who has many years of experience working in the health industry. Mr. Roche is available to assist health care companies through consulting arrangements through Roche Consulting, LLC and may be reached at [email protected].
Healthy Skeptic Podcast
This is an outstanding report on total global drug spending and trends, with projections out to 2025. It helps you understand this important area of health care, which does much...
June 1, 2021
MedPAC 2019 Report to Congress
June 18, 2019
Cano Health apparently cannot, as it declares bankruptcy due to too much debt. Building primary care centers to serve Medicare, Medicaid and commercial populations, which is Cano’s business, was hot...
February 6, 2024
Turquoise health raises a fresh $30 million in capital for its price transparency platform, as the market for funding health care companies isn’t quite dead yet.
January 24, 2024
I am co-f0under of a company that manages cell and gene therapy for health plans. Cell therapy has made a big difference for many cancer patients but like all new...
January 24, 2024
Access ACO Care Management Chronic Disease Comparative Effectiveness Consumer Directed Health Consumers Devices Disease Management Drugs EHRs Elder Care End-of-Life Care FDA Financings Genomics Government Health Care Costs Health Care Quality Health Care Reform Health Insurance Health Insurance Exchange HIT HomeCare Hospital Hospital Readmissions Legislation M&A Malpractice Meaningful Use Medicaid Medical Care Medicare Medicare Advantage Mobile Pay For Performance Pharmaceutical Physicians Providers Regulation Repealing Reform Telehealth Telemedicine Wellness and Prevention Workplace